TY - JOUR
T1 - Diffuse large B-cell lymphoma of the uterine cervix
T2 - A rare case managed novelly
AU - Baijal, Gunjan
AU - Vadiraja, B.
AU - Fernandes, Donald
AU - Vidyasagar, M.
PY - 2009/4/1
Y1 - 2009/4/1
N2 - Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.
AB - Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.
UR - http://www.scopus.com/inward/record.url?scp=67749120838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67749120838&partnerID=8YFLogxK
U2 - 10.4103/0973-1482.52784
DO - 10.4103/0973-1482.52784
M3 - Article
C2 - 19542675
AN - SCOPUS:67749120838
SN - 0973-1482
VL - 5
SP - 140
EP - 142
JO - Journal of Cancer Research and Therapeutics
JF - Journal of Cancer Research and Therapeutics
IS - 2
ER -